Bafiertam

Active Ingredient(s): Monomethyl Fumarate
FDA Approved: * April 28, 2020
Pharm Company: * BANNER LIFE SCIENCES
Category: Multiple Sclerosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bafiertam Overview

Monomethyl fumarate, sold under the brand name Bafiertam is a medication for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.[1] It was approved for medical use in the United States in April 2020.[2] The most common adverse reactions are flushing, abdominal pain, diarrhea, and nausea.[1] Contents 1 Pharmacology 2 Na...

Read more Bafiertam Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Monomethyl_fumarate

Recent Bafiertam Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Monomethyl Fumarate
  • Capsule, Delayed Release: 95mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bafiertam: (1 result)

Sorted by National Drug Code
  • 69387-001 Bafiertam 95 mg Oral Capsule by Banner Life Sciences LLC

Other drugs which contain Monomethyl Fumarate or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA